Loading
Latest filing published 03 Sept 2026 for Beta Bionics, Inc., €112k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Stephen Feider appears in our data through filings on Beta Bionics, Inc. shares, published by SEC (Form 4). Between 2 June 2026 and 2 September 2026, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 3 September 2026, reports a transaction of €112k in Beta Bionics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations